Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000476812 | SCV000547746 | uncertain significance | Fanconi anemia | 2022-07-19 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 475 of the FANCA protein (p.Thr475Met). This variant is present in population databases (rs761957732, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with FANCA-related conditions. ClinVar contains an entry for this variant (Variation ID: 408174). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002489042 | SCV002787997 | uncertain significance | Fanconi anemia complementation group A | 2022-02-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003317216 | SCV004021454 | uncertain significance | not provided | 2023-01-18 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003317216 | SCV005625420 | uncertain significance | not provided | 2024-10-02 | criteria provided, single submitter | clinical testing | The FANCA c.1424C>T (p.Thr475Met) variant has been reported in the published literature in in an individual with cutaneous melanoma (PMID: 29641532 (2018)). This variant has also been identified as a somatic variant in a prostate cancer tumor sample (PMID: 31874108 (2020)). The frequency of this variant in the general population, 0.000023 (3/129160 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is benign. Based on the available information, we are unable to determine the clinical significance of this variant. |
Natera, |
RCV000476812 | SCV002095034 | uncertain significance | Fanconi anemia | 2020-10-08 | no assertion criteria provided | clinical testing |